Nonobstructive Coronary Lesions and Ventricular Dysfunction

Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction.

Double Kissing Crush vs. Provisional Stenting

Patients with heart failure are frequently divided according to aetiology in ischemic and nonischemic. However, such binary classification combines patients with normal coronary arteries and patients with nonobstructive disease who might have a different prognosis.

This study divided patients with ventricular dysfunction into those with normal coronary arteries, nonobstructive disease, and obstructive disease.

The primary endpoint was a composite of cardiovascular death, nonfatal infarction, nonfatal stroke, and heart failure hospitalization.


Read also: The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results.


Of 12,814 patients, 2656 (20.7%) had normal coronary arteries, 2254 (17.6%) had nonobstructive disease, and 7904 (61.7%) had obstructive disease.

The risk of the primary endpoint was significantly higher in the nonobstructive group (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.32; p = 0.01) compared with the group with normal coronary arteries.


Read also: Patients: What They Really Want to Know about Their Disease.


Nonobstructive coronary artery disease was associated with an increase in cardiovascular death (HR: 1.82; 95% CI: 1.27 to 2.62; p = 0.001) and all-cause mortality (HR: 1.18; 95% CI: 1.05 to 1.33; p = 0.005). Still, there were no differences as regards acute myocardial infarction, stroke, or heart failure hospitalization.

Conclusion

Among patients with left ventricular dysfunction, the presence of nonobstructive coronary artery disease was independently associated with an increase in composite events and mortality.

Original title: Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.

Reference: Juarez R. Braga et al. J Am Coll Cardiol HF 2019, article in press.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...